The Giants Shoulder

#74 Psychedelics Expert: Who is Blocking Psychedelic Research? Cannabis Vs Alcohol, MDMA & Ayahuasca

Nov 13, 2025
Dr. Grace Blest-Hopley, a pioneering neuroscientist and psychedelics researcher focused on trauma and women's health, shares her groundbreaking insights. She discusses the contrasting risks of cannabis and alcohol, dispels myths about cannabis and psychosis, and highlights the therapeutic potential of MDMA for PTSD. Grace reveals why the FDA rejected MDMA trials and explores how psychedelics can treat addiction by rewiring the brain. She emphasizes the importance of cultural contexts and community in healing, and anticipates exciting future developments in psychedelic research.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Laws Driven By Politics, Not Risk

  • Drug laws do not reflect actual risk and are driven by cultural, historical, and political forces.
  • Rewriting laws based on evidence would dramatically change public health and criminal markets.
ANECDOTE

Veterans’ Transformations In Amazon Retreats

  • Dr. Grace Blest-Hopley watched veterans at Heroic Hearts transform after psychedelic retreats in the Amazon.
  • She reports long-lasting improvements in depression and PTSD measures from those experiences.
INSIGHT

Cannabis vs Alcohol Risk Differences

  • Alcohol causes widespread harm across all heavy users while cannabis harms depend on individual risk factors.
  • Cannabis is likely safer than daily alcohol for many adults but not for everybody.
Get the Snipd Podcast app to discover more snips from this episode
Get the app